Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A model assessing potential benefits of isolation and mass testing on COVID-19: the case of Nigeria

View ORCID ProfileFaraimunashe Chirove, Chinwendu E. Madubueze, Zviiteyi Chazuka, Sunday Madubueze
doi: https://doi.org/10.1101/2020.09.01.20186288
Faraimunashe Chirove
1University of Johannesburg, Department of Mathematics and Applied Mathematics, South Africa E-mail:
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Faraimunashe Chirove
  • For correspondence: fchirove{at}uj.ac.za fchirove{at}uj.ac.za
Chinwendu E. Madubueze
2Federal University of Agriculture, Department of Mathematics, Statistics and Computer Science, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zviiteyi Chazuka
3Chinhoyi University of Technology, School of Natural Sciences and Mathematics, Zimbabwe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sunday Madubueze
4Dalhatu Araf Specialist Hospital, Department of Family Medicine, Lafia, Nigeria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

We consider a model with mass testing and isolation mimicking the current policies implemented in Nigeria and use the Nigerian daily cumulative cases to calibrate the model to obtain the optimal mass testing and isolation levels. Mathematical analysis was done and important thresholds such the peak size relation and final size relation were obtained. Global stability analysis of the disease-free equilibrium indicated that COVID-19 can be eradicated provided that Embedded Image and unstable otherwise. Results from simulations revealed that an increase in mass testing and reduction of transmission from isolated individuals are associated with benefits of increasing detected cases, lowering peaks of symptomatic cases, increase in self-isolating cases, decrease in cumulative deaths and decrease in admissions into monitored isolation facilities in the case of Nigeria.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The corresponding author was funded by the University of Johannesburg URC grant funds

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Project does not require ethical approval.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Public data for Nigeria from NCDC (https://covid19.ncdc.gov.ng/)

https://covid19.ncdc.gov.ng/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 03, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A model assessing potential benefits of isolation and mass testing on COVID-19: the case of Nigeria
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A model assessing potential benefits of isolation and mass testing on COVID-19: the case of Nigeria
Faraimunashe Chirove, Chinwendu E. Madubueze, Zviiteyi Chazuka, Sunday Madubueze
medRxiv 2020.09.01.20186288; doi: https://doi.org/10.1101/2020.09.01.20186288
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A model assessing potential benefits of isolation and mass testing on COVID-19: the case of Nigeria
Faraimunashe Chirove, Chinwendu E. Madubueze, Zviiteyi Chazuka, Sunday Madubueze
medRxiv 2020.09.01.20186288; doi: https://doi.org/10.1101/2020.09.01.20186288

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)